相关实验视频

Updated: Jun 13, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

CDMPred:用于预测癌症驱动误解突变的工具,具有高质量的乘客突变

Lihua Wang^1,2, Haiyang Sun³, Zhenyu Yue⁴

¹Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui, China.

|September 10, 2024

概括

一个新的计算工具CDMPred,通过使用驾驶员和乘客的突变,准确地预测癌症驱动突变. 这种方法增强了对癌症遗传学的理解,并有助于开发个性化疗法.

科学领域:

计算生物学是一种计算生物学.
基因组学就是基因组学.
癌症研究癌症研究

背景情况:

预测癌症驱动突变对于个性化治疗至关重要.
现有的方法往往缺乏代表性的负样本,这可能会影响预测的准确性.

研究的目的:

开发一种可靠的计算方法来预测癌症驱动器错误的突变.
通过结合高质量的乘客突变来提高驾驶员突变预测的准确性.

主要方法:

编制了一套平衡的司机 (COSMIC) 和乘客突变数据集 (癌症乘客突变数据库).
编码的突变特征和利用的特征相关性分析.
开发CDMPred使用集体学习 (XGBoost) 进行特征选择.

主要成果:

在训练组中,CDMPred的AUC为0.83,在独立测试组中为0.80.
在使用AUC和精度回忆曲线下的面积的现有方法中表现出优异的性能.
包括高质量的乘客突变在内显著改善了预测性能.

结论:

CDMPred是准确预测癌症驱动突变的宝贵工具.
包含乘客突变可以增强计算模型的预测能力.
这项工作有助于更好地了解癌症遗传学和个性化医学.

关键词:

质量的基准标准质量的基准癌症癌症癌症癌症司机误解突变的预测和预测机器学习是机器学习.在XGBoost中使用.

更多相关视频

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

相关概念视频

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...